Timing of sentinel lymph node biopsy in patients with early breast cancer undergoing neoadjuvant therapy / 国际外科学杂志
International Journal of Surgery
; (12): 76-81, 2023.
Article
em Zh
| WPRIM
| ID: wpr-989409
Biblioteca responsável:
WPRO
ABSTRACT
Neoadjuvant therapy has been continuously improved the outcomes of early breast cancer patients, and more patients with positive axillary lymph node achieve complete pathological responds. The timing of sentinel lymph node biopsy for patients receiving neoadjuvant therapy has also had a new strategy, especially for the patients with clinical positive axillary lymph node before treatment and become clinical negative after neoadjuvant therapy, sentinel lymph node biopsy after neoadjuvant therapy has gradually become a standard axillary surgery procedure. However, there are still many differences in clinical practice domestic in China and abroad. This article discussed the timing of sentinel lymph node biopsy in patients with early breast cancer undergoing neoadjuvant therapy, in order to draw the attention of domestic surgical colleagues to this issue and promote standardized surgery and multidisciplinary cooperation.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
International Journal of Surgery
Ano de publicação:
2023
Tipo de documento:
Article